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Summary  The  acknowledgment  of  tricuspid  regurgitation  (TR)  as  a  stand-alone  and  progres-
sive entity,  worsening  the  prognosis  of  patients  whatever  its  aetiology,  has  led  to  renewed
interest in  the  tricuspid-right  ventricular  complex.  The  tricuspid  valve  (TV)  is  a  complex,
dynamic  and  changing  structure.  As  the  TV  is  not  easy  to  analyse,  three-dimensional  imaging,
cardiac magnetic  resonance  imaging  and  computed  tomography  scans  may  add  to  two-Cardiac  imaging;
Heart  valve  surgery
dimensional  transthoracic  and  transoesophageal  echocardiographic  data  in  the  analysis  of  TR.
Not only  the  severity  of  TR,  but  also  its  mechanisms,  the  mode  of  leaﬂet  coaptation,  the  degree
of tricuspid  annulus  enlargement  and  tenting,  and  the  haemodynamic  consequences  for  right
atrial and  right  ventricular  morphology  and  function  have  to  be  taken  into  account.  TR  is  func-
tional and  is  a  satellite  of  left-sided  heart  disease  and/or  elevated  pulmonary  artery  pressure
Abbreviations: 2D, two-dimensional; 3D, three-dimensional; CMR, cardiac magnetic resonance; CT, computed tomography; FTR, func-
tional tricuspid regurgitation; PAP, pulmonary artery pressure; PISA, proximal isovelocity surface area; RA, right atrium/atrial; RV, right
ventricle/ventricular; TA, tricuspid annulus; TOE, transoesophageal echocardiography; TR, tricuspid regurgitation; TTE, transthoracic
echocardiography; TV, tricuspid valve.
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most  of  the  time;  a  particular  form  is  characterized  by  TR  worsening  after  left-sided  valve
surgery, which  has  been  shown  to  impair  patient  prognosis.  A  better  description  of  TV  anatomy
and function  by  multimodality  imaging  should  help  with  the  appropriate  selection  of  patients
who will  beneﬁt  from  either  surgical  TV  repair/replacement  or  a  percutaneous  procedure  for
TR, especially  among  patients  who  are  to  undergo  or  have  undergone  primary  left-sided  valvular
surgery.
© 2015  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé  Il  est  maintenant  bien  admis  que  l’insufﬁsance  tricuspide  (IT)  signiﬁcative  est  une
entité propre  qui  aggrave  le  pronostic  des  patients,  quelle  que  soit  son  étiologie,  et  ceci  a
conduit à  un  regain  d’intérêt  pour  l’ensemble  valve  tricuspide-ventricule  droit.  La  valve  tri-
cuspide est  une  structure  complexe,  dynamique  avec  une  grande  variabilité  interindividuelle.
Les différentes  techniques  d’imagerie  moderne  telles  que  l’échographie  tridimensionnelle,
l’imagerie  par  résonance  magnétique  et  le  scanner  peuvent  être  utilisés  en  complément  de
l’imagerie bidimensionnelle  classique  pour  analyser  l’IT.  Il  est  important  d’analyser  non  seule-
ment le  degré  de  sévérité  de  l’IT,  mais  aussi  les  mécanismes  à  son  origine,  le  mode  de  coaptation
des feuillets  valvulaires,  le  degré  d’élargissement  de  l’anneau  tricuspide  et  l’importance  de  la
traction  sur  les  feuillets  valvulaires,  ainsi  que  le  retentissement  hémodynamique  sur  l’oreillette
et le  ventricule  droit.  L’IT  est  dans  la  majorité  des  cas  fonctionnelle  et  satellite  d’une  patholo-
gie du  cœur  gauche  et/ou  d’une  élévation  des  pressions  pulmonaires.  L’IT  qui  persiste  et  se
majore dans  les  suites  d’une  chirurgie  valvulaire  du  cœur  gauche  est  une  forme  particulière
à ne  pas  méconnaître  car  elle  pose  des  problèmes  de  prise  en  charge  et  aggrave  le  pronostic
des patients.  Une  description  détaillée  de  l’anatomie  et  de  la  fonction  de  la  valve  tricuspide
et de  l’ensemble  du  cœur  droit  par  l’imagerie  multi-modalités  devrait  permettre  d’afﬁner  les
critères de  sélection  des  patients  chez  qui  une  correction  de  l’IT  doit  être  envisagée,  partic-
ulièrement  parmi  les  patients  candidats  à  une  chirurgie  du  cœur  gauche.  De  plus,  ces  éléments
doivent entrer  en  ligne  de  compte  dans  le  choix  de  la  modalité  thérapeutique  optimale,  à  savoir
réparation,  remplacement  valvulaire  ou  traitement  par  voie  percutanée.
© 2015  Elsevier  Masson  SAS.  Tous  droits  réservés.
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he  differences  in  anatomy  and  function  between  the
itral  valve  and  the  tricuspid  valve  (TV)  have  been  rec-
gnized  since  the  anatomical  descriptions  of  the  heart  by
illiam  Harvey  in  1628.  Tricuspid  regurgitation  (TR)  was  ﬁrst
escribed  by  T.W.  King  in  1837,  who  showed  that  distension
f  the  right  ventricle  (RV)  with  water  induced  considerable
V  reﬂux.  The  authors  thought  that  the  TV,  being  weak,
ould  act  as  a  safety  valve  for  the  RV,  and  concluded  that
‘the  TV  is  designed  to  be(come)  incompetent’’  [1]. This
tatement  was  accepted  as  true,  and  for  a  long  time  the  TV
nd  TR  were  neglected  while  surgical  techniques  for  treat-
ng  left  heart  valvular  diseases  evolved.  Unfortunately,  TR
urned  out  not  to  be  as  benign  and  physiological  as  had
een  thought.  Some  patients  with  progressive  TR  developed
ntractable  right  ventricular  (RV)  failure,  especially  those
ho  had  been  operated  on  earlier  for  left  heart  valve  dis-
ases  without  concomitant  TV  surgery.  These  ﬁndings  led  to
 renewed  interest  in  the  TV  and,  more  globally,  in  the  right
eart  valvular-ventricular  complex.  Multimodality  imaging
elped  to  better  describe  the  morphology  and  function  of
he  TV,  and  to  fully  assess  the  cause  and  impact  of  TR.  This
a
a
assue  of  TR  is  clinically  important  because  it  may  presage  a
oor  prognosis,  and  because  surgical  management  of  TR  is
ar  less  codiﬁed  than  for  left  heart  valves,  and  has  poorer
esults  and  frustrating  failures.  This  review  will  focus  on  the
ultimodality  imaging  of  the  normal  TV,  and  on  the  patho-
hysiology,  mechanisms  and  analysis  of  TR.
natomy
he  TV  is  a  complex  entity  of  thin  ﬁbrous  tissue,  with  three
eaﬂets,  chordae  tendineae,  papillary  muscles  and  a  ﬁbrous
nnulus  located  between  the  right  atrium  (RA)  and  the  RV
2—4].  The  normal  area  of  the  TV  is  7—9  cm2, making  it  the
argest  of  the  four  cardiac  valves.
ricuspid valve leaﬂets
he  TV  is  nearly  vertical  and  is  oriented  at  approximately
5◦ to  the  sagittal  plane,  so  that  the  margins  of  the  valve
re  anterosuperior,  inferior  and  septal  [5].  The  three  leaﬂets
re  the  anterior,  septal  and  posterior  leaﬂets,  which  are  thin
nd  membranous,  with  commissures  that  appear  more  like
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TTricuspid  valve  imaging  and  tricuspid  regurgitation  
indentations  than  true  commissures.  The  anterior  leaﬂet  is
the  largest,  with  a  semi-circular  shape,  and  stretches  from
the  infundibulum  anteriorly  to  the  inferolateral  wall  poste-
riorly.  The  posterior  leaﬂet  differs  because  of  the  presence
of  multiple  scallops;  it  attaches  along  the  posterior  mar-
gin  of  the  tricuspid  annulus  (TA)  from  the  septum  to  the
inferolateral  wall.  The  septal  leaﬂet  is  the  smallest,  and
arises  medially,  directly  from  the  annulus  above  the  inter-
ventricular  septum.  The  septal  leaﬂet  is  characteristically
inserted  ≤  10  mm  more  apically  than  the  septal  insertion  of
the  anterior  mitral  valve  leaﬂet.
Tricuspid subvalvular apparatus
The  TV  apparatus  is  similar  to  the  mitral  valve,  but  has
greater  variability.  The  tricuspid  subvalvular  apparatus  con-
sists  of  anterior,  posterior  and  septal  papillary  muscles,
and  their  true  chordae  tendineae.  Each  leaﬂet  has  chordal
attachments  to  one  or  more  papillary  muscles.  The  anterior
papillary  muscle,  the  most  prominent,  provides  chordae  to
the  anterior  and  posterior  leaﬂets,  and  the  medial  papillary
muscle  provides  chordae  to  the  posterior  and  septal  leaﬂets.
The  anterior  papillary  muscle  may  have  attachments  to  the
moderator  band.  The  posterior  papillary  muscle  is  smaller,
and  is  missing  in  20%  of  healthy  subjects  [6].  The  sep-
tal  wall  gives  chordae  directly  to  the  anterior  and  septal
leaﬂets,  without  a  speciﬁc  septal  papillary  muscle.  In  addi-
tion,  there  may  be  accessory  chordal  attachments  to  the  RV
free  wall  and  to  the  moderator  band.  These  multiple  chordal
attachments  are  important  mediators  of  TR,  as  they  impair
proper  leaﬂet  coaptation  in  the  setting  of  RV  dysfunction
and  adverse  remodelling.
Tricuspid annulus
The  TV  leaﬂets  are  attached  to  a  ﬁbrous  annulus  that  is
not  as  easy  to  deﬁne  as  it  is  around  the  mitral  valve,
although  it  remains  identiﬁable  [7].  The  septal  leaﬂet,  the
least  mobile  of  the  three  leaﬂets,  has  more  support  from
the  ﬁbrous  trigone  than  other  leaﬂets.  The  normal  TA  is
ovoid,  and  appears  approximately  one  third  longer  in  the
mediolateral  than  in  the  anteroposterior  direction  [8].  Fur-
thermore,  the  TA  is  non-planar,  with  an  elliptical  saddle
shape.  The  posteroseptal  portion  (close  to  the  coronary
sinus)  and  the  anterolateral  segments  are  the  closest  to
the  apex  and  the  anteroseptal  (close  to  the  RV  outﬂow
tract  and  the  aortic  valve)  and  posterolateral  segments  are
the  closest  to  the  RA,  with  a  high-low  distance  of  around
7  mm  [9].  The  mean  maximal  TA  circumference  and  area
in  healthy  subjects  are  12  ±  1  cm  and  11  ±  2  cm2,  respec-
tively.  The  TA  diameter  varies  according  to  the  site  of
measurement,  with  reference  values  varying  between  25
and  39  mm  [8,9].  From  a  dynamic  point  of  view,  the  TA  shows
variability  during  the  cardiac  cycle,  with  an  approximately
20%  reduction  in  annular  circumference  with  atrial  systole
[10].  In  pathological  situations,  as  the  septal  leaﬂet  is  ﬁxed
between  the  ﬁbrous  trigones,  the  TA  can  only  lengthen  and
dilate  along  the  attachment  of  the  anterior  and  posterior
leaﬂets,  resulting  in  a  more  circular  shape;  furthermore,  it
then  becomes  more  planar  with  decreased  high-low  distance
(<  4  mm)  [8,9,11,12].
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chocardiographic imaging of the tricuspid
alve complex
ssessment  of  the  TV  using  transthoracic  echocardiography
TTE)  is  challenging  because  of  its  unfavourable  retroster-
al  position,  the  high  variability  of  the  TV  anatomy  and
he  difﬁculty  in  simultaneously  visualizing  all  three  leaﬂets
n  standard  two-dimensional  (2D)  views;  hence,  all  exist-
ng  echocardiographic  TV  leaﬂet  identiﬁcation  schemes  are
nly  partially  correct.  The  use  of  an  en-face  view  obtained
y  2D  TTE  or,  more  easily,  by  transoesophageal  echocardiog-
aphy  (TOE)  and  three-dimensional  (3D)  imaging  is  therefore
ecommended  [13,14].
ricuspid valve morphology
V  morphology  can  be  evaluated  by  2D  TTE  from  the
tandard  parasternal  and  apical  RV  views:  RV  inﬂow,
arasternal  short-axis,  apical  four-chamber  and  subcostal
iews  (Fig.  1).  It  is  important  to  use  all  available  views
n  2D,  colour  and  Doppler  modes  to  obtain  a  complete
valuation  of  the  valve  by  2D  TTE,  and  to  rule  out  and
ot  underestimate  a  ﬂail  leaﬂet  or  a  localized  abnor-
ality.  TOE  helps  to  image  the  TV  in  multiple  views
nd  planes,  although  the  incremental  value  of  TOE  is
sually  less  for  the  TV  than  for  the  mitral  valve.  The
eeper  gastric  view  in  a  longitudinal  plane  (transgastric
V  inﬂow  view)  often  provides  a  nice  long-axis  visualiza-
ion  of  the  TV  and  the  subvalvular  apparatus.  An  en-face
iew  is  also  quite  easily  obtained  from  the  gastric  approach
Fig.  2).
Finally,  3D  imaging  is  used  mostly  in  TTE,  from  either
he  parasternal  or  the  apical  approach,  with  real-time  zoom
ode  or  after  acquisition  of  a  full-volume  data  set;  this
llows  the  display  of  the  TV  surgical  view  and  visualiza-
ion  of  all  the  components  of  the  TV,  enabling  assessment
f  their  dynamic  spatial  relationships  and  anatomical  con-
inuity  [14—16]  (Fig.  3).  In  patients  with  good  echogenicity,
ssessment  of  TV  anatomy  and  function  with  3D  TTE  is  often
easible,  even  if  it  is  more  difﬁcult  and  requires  more  expe-
ience  compared  with  mitral  valve  3D  evaluation  [14].  3D
TE  has  the  potential  advantage  of  evaluating  complex  TV
natomy  in  organic  TR,  as  may  be  encountered  in  Ebstein’s
nomaly,  carcinoid  heart  disease  and  TV  prolapse  [17—19].
ecently,  several  publications  have  highlighted  the  useful-
ess  of  3D  TTE  for  detecting  the  location  of  the  lead  and  its
elationship  to  valvular  leaﬂets  and  signiﬁcant  TR  in  patients
ith  intracardiac  devices  [20—22]. 3D  TTE  also  enables  us  to
ocate  the  anatomical  regurgitant  oriﬁce  of  TR  and  to  mea-
ure  the  vena  contracta,  which  was  found  to  be  more  often
llipsoid  than  circular  [23].  Finally,  the  extent  of  TV  tether-
ng  may  be  quantiﬁed  with  3D  echocardiography,  in  terms  of
he  tenting  volume  and  tenting  angle  of  the  three  leaﬂets
24,25].
ricuspid annulusA  size  and  function  play  pivotal  roles  in  the  genesis  of  TR,
nd  accurate  analysis  of  the  TA  is  required  to  determine  the
eed  for  a  combined  procedure  on  the  TV  in  patients  under-
oing  cardiac  surgery  for  left-sided  valve  diseases.  However,
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Figure 1. Two-dimensional transthoracic imaging of the tricuspid valve. RV: right ventricle; TV: tricuspid valve; AL: anterior leaﬂet; PL:
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tosterior leaﬂet; SL: septal leaﬂet.
ormative  data  about  TA  diameter  and  function  are  limited,
nd  are  still  a  matter  of  debate.As  for  the  description  of  TV  morphological  details,  2D
TE  has  some  limitations  in  the  quantiﬁcation  of  the  TA
iameter  [26,27].  In  fact,  the  2D  view  and  the  timing
uring  the  cardiac  cycle  of  when  the  TA  should  be  measured
b
c
r
aemain  controversial  [10].  If  2D  TTE  is  the  only  assessment
ool  available,  the  apical  four-chamber  view  seems  to
e  preferred,  because  of  better  interobserver  agreement
ompared  with  other  views  [28],  and  it  is  the  method
ecommended  by  current  guidelines  for  making  a  decision
bout  TV  repair  [29,30].  In  this  view,  the  normal  TA  diameter
Tricuspid  valve  imaging  and  tricuspid  regurgitation  71
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MFigure 2. Two-dimensional transoesophageal imaging of the tric
leaﬂet; PL: posterior leaﬂet; SL: septal leaﬂet.
in  adults  is  28  ±  5  mm,  measured  in  diastole.  The  TA  can
also  be  measured  from  the  mid-oesophageal  four-chamber
view  in  2D  TOE  (Fig.  4).
To  assess  cyclic  changes  in  TA  diameter  during  systole  and
diastole,  TA  fractional  shortening  may  be  calculated  from
the  apical  four-chamber  view  between  the  insertion  sites
of  the  septal  and  anterior  TV  leaﬂets  at  end-diastolic  and
end-systolic  times;  the  normal  value  is  around  25%  [28].
The  analysis  of  TA  geometry  and  size  with  the  use
of  3D  echocardiography  shows  interesting  results  and
has  good  feasibility  [8,9,11,29,31—34]  (Fig.  4).  Various
measurements  are  reported,  including  major  and  minor  TA
diameters,  TA  fractional  shortening,  TA  area  and  TA  frac-
tional  area  change.  TA  diameter  is  usually  underestimated
by  2D  TTE  compared  with  3D  TTE,  and  it  seems  necessary
to  re-establish  normal  TA  values  with  3D  imaging.  Fur-
thermore,  more  complicated  analysis  of  the  non-planarity
of  TA  can  also  be  performed  from  3D  acquisitions,  which
have  potentially  important  mechanistic  and  therapeutic
implications  for  TV  repair  [8,11].
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C valve (TV). RV: right ventricle; TV: tricuspid valve; AL: anterior
alue of other imaging modalities in the
ssessment of the tricuspid valve
lectrocardiograph-gated  computed  tomography  (CT)  scans
nd  cardiac  magnetic  resonance  (CMR)  imaging  are  interest-
ng  adjuncts  in  the  evaluation  of  the  TV.
omputed tomography scans
he  dynamic  data  set  acquired  in  patients  who  undergo  CT
cans  can  be  used  to  assess  RV  function.  The  thin  slice  thick-
ess  facilitates  increased  accuracy  of  RV  delineation,  and
llows  for  precise  recognition  of  the  valvular  borders.  For
he  TV,  only  static  anatomical  information  is  relevant  [35].
easurements  of  TA  diameter  and  assessment  of  lack  of
oaptation  of  leaﬂets  are  generally  simple  on  good-quality
our-chamber  cardiac  CT  images  (Fig.  5).  Evaluation  of  TV
rolapse  is  easier  on  coronal  views.  In  functional  TR  (FTR),
T  scans  have  been  used  to  measure  right  atrial  (RA)  and
72  O.  Huttin  et  al.
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Aigure 3. Three-dimensional (3D) imaging of the tricuspid valve
osterior leaﬂet; SL: septal leaﬂet; RT3DE: real-time 3D echocardio
V  volumes,  TA  diameters  and  areas,  the  distance  between
ach  commissure,  the  tethering  angle  of  each  leaﬂet  and  the
ethering  height,  with  these  various  indexes  having  interest-
ng  prognostic  value  [36,37].  Some  other  potential  beneﬁts
f  CT  scans  are  the  detection  of  valvular  calciﬁcations,  the
valuation  of  TV  annuloplasty  ring  dislodgement  and  the
ssessment  of  the  spatial  relationship  between  RV  pace-
aker  leads  and  related  TR  [35].ardiac magnetic resonance imaging
ith  its  ability  to  image  in  any  plane,  CMR  can  provide
etailed  characterization  of  all  valvular  structures  [38,39].
3
m
T
t. RV: right ventricle; TV: tricuspid valve; AL: anterior leaﬂet; PL:
hy.
ost  morphological  and  functional  information  is  obtained
sing  cine  CMR  sequences,  particularly  steady-state  free
recession  sequences.  In  addition  to  echocardiography,  CMR
s  the  technique  of  choice  for  evaluating  tricuspid  abnor-
ality  [40].  As  for  CT  scans,  2D  measurements  of  annulus
iameter,  tethering  height  and  lack  of  coaptation  of  leaﬂets
ith  direct  planimetry  of  the  valvular  oriﬁce  area  are  feasi-
le  using  the  different  sequences  focused  on  the  RV  (Fig.  5).
 semiautomatic  algorithm  based  on  cine  CMR  images  and
D  reconstruction  can  help  to  assess  TA  morphology  and
otion  and  to  better  depict  its  ellipsoid  saddle  shape  [41].
A  dynamics  have,  in  this  way,  been  shown  to  be  minimal  in
he  anteroseptal  region  and  maximal  in  the  posterior  region
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Figure 4. Tricuspid annulus (TA) diameter assessment by two-dimensional (2D) and three-dimensional (3D) transthoracic echocardiography.
(Top) 2D apical four-chamber and subcostal long-axis view with end-diastolic TA measurement. (Bottom left) Volume rendering of the TA
shown from the right ventricular perspective. The ‘‘laser lines’’ superimposed on the 3D echocardiography rendering indicate the orientation
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lof the corresponding depicted image in the longitudinal 2D views 
the end-diastolic 3D frame of the TA.
[42].  Finally,  CMR  is  currently  the  gold  standard  for  the
assessment  of  RV  morphology  and  function,  and  is  therefore
of  great  interest  in  the  ﬁeld  of  TR.
Tricuspid regurgitation
TV  function  depends  on  interactions  between  the  TA,  valvu-
lar  leaﬂets,  papillary  muscles,  chords,  the  RA  and  the  RV.  Any
congenital  or  acquired  abnormality  affecting  one  of  these
structures  leads  to  TR.
Epidemiology
Mild  physiological  TR  is  very  frequent  and  well  known
by  echocardiographers  who,  by  applying  the  simpliﬁed
Bernoulli  formula,  use  its  maximal  velocity  to  estimate  sys-
tolic  pulmonary  artery  pressure  (PAP)  [43].  Depending  on
the  series,  physiological  TR  is  reported  to  be  present  in
60—90%  of  people  who  undergo  echocardiography,  and  its
incidence  increases  with  age.  TR  is  mostly  trivial  or  mild.  In
the  Framingham  study,  the  prevalence  of  mild  or  greater  TR
by  colour  Doppler  was  15%  in  men  and  18%  in  women  [44].
In  a  large  database  of  more  than  60,000  echocardiograms,
TR  was  reported  to  be  severe  in  only  1.2%  of  patients  [45].
It  is  estimated  that  moderate-to-severe  TR  affects  approxi-
mately  1.6  million  patients  in  the  USA  [7].Aetiologies and mechanisms
As  for  the  mitral  valve,  the  aetiology  of  TR  is  divided  into
organic  TR  (TV  pathology)  and  FTR  (secondary  to  other
S
I
a tricuspid valve. (Bottom right) Measurements of diameters from
ardiac  pathology).  Some  authors  also  individualize  idio-
athic  TR  (normal  TV  and  no  aetiology  identiﬁed  for  TR)
46]. In  a series  of  768  cases  of  severe  TR,  organic  TR  and
TR  represented  11%  and  80%  of  the  cases,  respectively,  and
diopathic  TR  accounted  for  9%,  with  these  patients  being
lder  and  having  a  higher  frequency  of  AF  than  the  others
45]. Carpentier’s  classiﬁcation  based  on  the  amplitude  of
alvular  displacement  (normal  for  type  1,  excessive  for  type
 and  restrictive  for  type  3)  can  also  be  applied  to  describe
he  mechanisms  of  TR  (Table  1).
athophysiology
R  is  responsible  for  progressive  RA  dilatation,  increased
ulsatility  and  dilatation  of  the  inferior  vena  cava  and
epatic  veins,  coronary  sinus  dilatation  and  septal  shift
owards  the  left  atrium.  Whatever  the  initial  mechanism,  TR
lso  leads  to  RV  volume  overload  and  increased  RV  diastolic
ressure,  septal  shift  towards  the  left  ventricle  and  increas-
ng  RV  dilatation,  with  displacement  of  papillary  muscles  and
eaﬂet  tethering,  decreased  amplitude  of  leaﬂet  motion  and
alvular  tenting  further  impairing  valvular  coaptation.  This
icious  circle  progressively  increases  TR  and  decreases  car-
iac  output,  leading  to  ﬁnal  RV  failure.  In  addition,  atrial
brillation,  which  often  complicates  all  these  pathologies,
eads  to  a  further  annular  dilation  (Fig.  6).ymptoms
n  advanced  stages  of  TR,  there  is  the  progressive  appear-
nce  of  venous  dilation,  with  signs  of  right-sided  heart
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Figure 5. Cardiac magnetic resonance (CMR) imaging and computed tomography (CT) scans of the tricuspid valve (TV). RV: right ventricle;
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OV: tricuspid valve; AL: anterior leaﬂet; PL: posterior leaﬂet; SL: se
tate free precession cine MRI; MinIP: minimal intensity projection.
ailure,  such  as  congestive  hepatopathy,  loss  of  appetite,
scites,  gut  congestion  with  symptoms  of  dyspepsia  or  feel-
ng  of  abdominal  fullness  and  ﬂuid  retention  with  peripheral
edema.  Furthermore,  the  decrease  in  cardiac  output  is
esponsible  for  fatigue,  exertional  dyspnoea  and  decreased
unctional  capacity  [27,47,48].
O
v
T
nleaﬂet; SV: stroke volume; HLA: horizontal long-axis; SSFP: steady-
rganic/primary tricuspid regurgitationrganic  TR  results  from  structural  abnormalities  of  the
alvular  apparatus,  which  are  either  congenital  or  acquired.
able  1  summarizes  the  main  causes  and  mechanisms  of
on-congenital  organic  TR.  Some  recent  reports  insist  on
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Table  1  Causes  and  mechanisms  of  tricuspid  regurgitation.
Organic  Functional
Type  1  Type  2  Type  3  Type  1/
Endocarditis  (perforation)
Congenital  (cleft  leaﬂet)
PM  leads
Degenerative  (prolapse)
Endocarditis  (ruptured
chordae)
Traumatic  (ruptured
chordae)
Rheumatic  iatrogenic
(radiation/drug)
Carcinoid
PM  leads
Left heart  disease  (valvular,
myocardial)
Left-sided  valve  surgery
Primitive  RV  dysfunction
(cardiomyopathy,  ischemic)
Secondary  RV  dysfunction/dilation
(PAH,  pulmonary  diseases)
F
F
t
N
t
a
da  peculiar  form  of  TR  related  to  stimulation  device  leads
(pacemaker,  cardiac  resynchronization  therapy,  implantable
cardioverter  deﬁbrillator).  Those  leads  have  been  reported
to  cause  TR  of  variable  degree.  With  the  help  of  3D  echocar-
diography,  a  clear  association  between  device  lead  position
and  TR  was  found,  regurgitation  being  more  frequent  when
the  leads  are  impinging  on  the  leaﬂets  and  interfering  with
their  mobility  than  when  placed  in  a  commissural  position
[22].  Furthermore,  the  presence  of  an  interfering  lead  is  a
factor  associated  with  TR  worsening,  increasing  the  likeli-
hood  of  developing  moderate  or  severe  TR  by  more  than
10-fold  [20].
d
d
m
Figure 6. Pathophysiology of tricuspid regurgitation. ARVD: arrhythmog
RA: right atrial; RV: right ventricular.unctional/secondary tricuspid regurgitation
TR  is  deﬁned  as  the  leakage  of  the  TV  during  systole  in
he  presence  of  structurally  normal  leaﬂets  and  chordae.
evertheless,  in  case  of  signiﬁcant  TR,  it  entails  abnormali-
ies  of  the  valvular  apparatus,  with  tricuspid  annular  dilation
nd  tricuspid  leaﬂet  tethering  secondary  to  RV  dilation  and
ysfunction  [49].Dilation  of  the  TA  occurs  primarily  in  the  septolateral
irection,  resulting  in  a  less  oval  oriﬁce  [50].  3D  echocar-
iography  has  determined  that  not  only  dilation,  but  also
odiﬁcations  of  the  structure  of  the  TA  exist  in  FTR  patients,
enic right ventricular dysplasia; LA: left atrial; LV: left ventricular;
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ith  a  more  planar  TA  than  in  healthy  subjects  [8,11]. Loss
f  longitudinal  ﬂexibility  and  more  restricted  movement  of
he  TA  have  also  been  shown  by  CMR  in  the  early  stages  of
TR,  resulting  in  leaﬂet  tethering  even  in  the  absence  of
V  dilation  [51].  Leaﬂet  tethering  following  displacement
f  papillary  muscles  caused  by  progressive  RV  distortion  and
ccentricity  also  inﬂuence  the  development  of  FTR  [7].  All
hese  mechanisms  are  variously  implicated  in  the  devel-
pment  of  FTR.  For  instance,  Topilsky  et  al.  showed  that
n  idiopathic  FTR,  excess  annular  and  RV  inﬂow  enlarge-
ent  exhausts  valvular/annular  coverage  reserve,  and  RV
onical  deformation  does  not  cause  notable  valvular  tent-
ng.  Conversely,  in  pulmonary  hypertension,  FTR  is  mostly
etermined  by  valvular  tethering,  with  tenting  linked  to  RV
longation  and  elliptical/spherical  deformation  [52].
The  most  common  cause  of  FTR  is  left  heart  disease,
ncluding  advanced  mitral,  aortic  and/or  left  ventricular
yocardial  disorder.  FTR  may  also  complicate  either  pul-
onary  (pulmonary  diseases,  pulmonary  hypertension)  or
ntrinsic  (RV  cardiomyopathy,  arrhythmogenic  RV  dysplasia,
V  infarction,  endomyocardial  ﬁbrosis,  etc.)  RV  myocardial
iseases  (Fig.  6).  Elevated  PAP  is  a  strong  determinant  of
he  presence  of  signiﬁcant  TR  and  of  TR  severity,  although
any  patients  with  pulmonary  hypertension  do  not  exhibit
igniﬁcant  TR  [53].  So,  more  than  just  the  absolute  value
f  the  PAP,  remodelling  of  the  right  heart  in  response  to
levated  PAP  and  its  causes  is  one  of  the  factors  at  the  ori-
in  of  FTR.  In  a  large  series  of  more  than  2000  patients
ho  had  TR-derived  estimation  of  PAP,  demographic  char-
cteristics  (age,  female  sex),  mechanical  factors  (presence
f  pacemaker  leads),  remodelling  of  the  right  heart  cavi-
ies  (RA,  RV  enlargement)  and  other  factors  (e.g.  organic
itral  valve  disease,  possibly  reﬂecting  the  presence  of
trial  ﬁbrillation  or  occult  organic  TV  disease)  were  predic-
ive  of  TR  severity  in  addition  to  PAP  [54].  In  a  case-control
tudy  on  the  follow-up  of  patients  with  mild  TR,  progressive
ncrease  in  PAP,  atrial  ﬁbrillation  and  coronary  artery  dis-
ase  were  independent  predictive  factors  of  TR  progression
55].
unctional tricuspid regurgitation in the
ollow-up of left heart valve surgery
ne  peculiar  form  of  FTR  complicating  left  heart  diseases
s  represented  by  FTR  appearing  in  the  follow-up  of  left-
ided  valve  surgery;  this  is  quite  frequent  after  mitral  valve
urgery  and  may  occur  whatever  the  type  of  procedure
repair  or  replacement)  or  valvular  substitute  (biological  or
echanical).  Until  recently,  it  was  believed  that  surgical
orrection  of  left-sided  lesions  would  lead  to  the  disappear-
nce  of  secondary  TR.  However,  if  not  treated  during  the
nitial  surgery,  pre-existing  FTR  may  persist  and  worsen  over
ime.  In  the  presence  of  severe  TR  associated  with  degener-
tive  mitral  valve  disease,  mitral  valve  repair  alone  leads  to
mproved  TR  and  RV  function;  however,  this  improvement  is
ncomplete  and  temporary,  and  TR  and  RV  function  worsen
oward  preoperative  levels  within  3  years  [56].  Moreover,
ate  occurrence  of  signiﬁcant  TR  long  after  the  initial  sur-
ical  procedure  has  been  shown  to  be  quite  common  after
itral  surgery,  and  is  associated  with  a  poor  prognosis  in
erms  of  morbidity  and  mortality  [57].
o
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Many  factors  inﬂuencing  the  occurrence  of  signiﬁcant  TR
uring  the  follow-up  of  mitral  surgery  have  been  reported:
lder  age,  female  sex,  rheumatic  fever  as  the  origin  of
itral  dysfunction,  long  period  of  valvular  disease  before
urgery,  atrial  ﬁbrillation,  level  of  preoperative  PAP  and
reoperative  RV  dysfunction.  Furthermore,  preoperative  TA
ilation  [58,59]  and  the  tethering  height  and  tenting  vol-
me  of  TV  are  important  independent  predictors  of  late  TR
36].
The  type  of  underlying  mitral  disease  justifying  initial
urgery  probably  also  plays  a  role  in  the  occurrence  of  sig-
iﬁcant  TR.  TR  seems  to  be  more  frequent  in  case  of  initial
urgery  for  ischaemic  MR,  reported  as  being  as  high  as  74%
fter  3  years  of  follow-up  [60],  than  in  case  of  surgery  for
rganic  MR,  where  <  20%  of  patients  had  severe  TR  after  a
-year  follow-up  period  [61].  It  has  even  been  reported  that
linically-silent  non-severe  TR  is  unlikely  to  progress  after
itral  valve  repair  for  degenerative  prolapse  [62].  How-
ver,  these  discrepancies  between  ischaemic  and  organic
rigin  of  initial  mitral  valve  disease  are  the  result  of  unclear
echanisms  [63]; concomitant  RV  dysfunction  in  ischaemic
iseases  probably  plays  a  role  in  the  higher  late  occurrence
f  signiﬁcant  TR.
FTR  is  also  seen  in  patients  with  aortic  stenosis,  per-
isting  in  a  signiﬁcant  degree  after  valvular  replacement  in
round  15%  of  the  patients,  with  a  further  progression  in  half
f  these  patients.  As  for  the  mitral  valve,  persistent  FTR
reater  than  mild  was  associated  with  a  worse  long-term
rognosis  [64].
elationship between tricuspid regurgitation
nd right ventricular function
he  relationship  between  TR  and  RV  function  is  complex.  RV
ysfunction  mostly  inﬂuences  TR  severity  through  RV  remod-
lling  [65].  The  inﬂuence  of  severe  TR  on  RV  function  is  less
lear.
Experimentally,  it  has  been  shown  that  severe  TR  in
ogs  leads  to  pump  failure,  but  without  cellular  contractile
ysfunction,  suggesting  a  relative  preservation  of  intrinsic
V  contractile  function  despite  severe  TR  [66].  Likewise,
ld  series  of  tricuspid  valvulectomy  have  shown  relatively
ood  tolerance  at  mid-term  follow-up  in  around  two-
hirds  of  patients,  without  signs  of  congestive  heart  failure
67,68].
On  the  other  hand,  echocardiographic  variables  of  RV
unction  have  been  shown  to  alter  in  parallel  with  the
ncrease  in  TR  severity  [69]. The  effect  of  TR  on  RV  func-
ion  variables  varies  according  to  the  mechanisms  of  TR,
ut  signiﬁcant  TR  always  leads  to  increased  end-systolic
V  size  and  RV  myocardial  performance  index  in  both  idio-
athic  FTR  and  FTR  secondary  to  pulmonary  hypertension,
ith  an  additional  decrease  in  RV  fractional  area  change  in
diopathic  FTR,  and  an  increase  in  RV  end-diastolic  area  in
TR  secondary  to  pulmonary  hypertension,  suggesting  uni-
ersally  reduced  RV  function  with  increasing  FTR  severity
52].Finally,  RV  function  seems  to  improve  after  correction
f  isolated  TR  [70], with  a  reduction  in  RV  volumes  [40];
his  is  also  the  case  when  mitral  and  tricuspid  surgery  are
ombined  [56]. In  the  same  manner,  it  has  been  shown
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that  the  degree  of  both  RV  dysfunction  and  TR  sever-
ity  improves  after  pulmonary  endarteriectomy  in  chronic
thromboembolic  pulmonary  hypertension  [71,72].  These
studies  suggest  that  severe  TR  leads  to  RV  dysfunction;  how-
ever,  RV  function  seems,  in  some  cases,  to  improve  after
surgical  treatment  of  either  TR  or  the  aetiology  of  increased
RV  afterload  that  is  responsible  for  TR.  The  real  challenge
is  actually  to  correctly  identify  patients  whose  RV  function
is  deemed  good  enough  for  the  heart  to  take  advantage  of
a  competent  TV  [73].
The  main  issue  is  that  echocardiographic  variables  of  RV
function  and  even  CMR-derived  RV  ejection  fraction  are  well
known  to  be  load  dependent  and  not  to  be  a  proper  reﬂec-
tion  of  intrinsic  RV  contractility  [74,75];  the  real  impact
of  severe  TR  on  intrinsic  RV  contractile  function  and  on
its  potential  reversibility  is  therefore  difﬁcult  to  assess.
Furthermore,  it  has  been  shown  that  echocardiographic
variables  of  RV  function  may  be  altered  in  the  follow-up
of  cardiac  surgery,  even  in  the  absence  of  real  RV  dysfunc-
tion,  so  that  the  true  impact  of  TR  correction  on  RV  function
is  also  very  difﬁcult  to  comprehend  [76,77].  Nevertheless,
preserved  RV  function  variables  in  the  presence  of  signiﬁ-
cant  TR  are  always  associated  with  a  better  prognosis  than
altered  ones  [56,78,79].
Echocardiographic analysis of tricuspid
regurgitation
As  for  every  other  valve,  the  echocardiographic  analysis
of  TR  encompasses  a  description  of  TV  morphology,  quan-
tiﬁcation  of  TR  and  the  assessment  of  its  haemodynamic
consequences.
The  quantiﬁcation  of  TA  enlargement,  the  mode  of  leaﬂet
coaptation  and  the  degree  of  tenting  are  of  utmost  impor-
tance  when  making  a  surgical  decision  about  TV  repair  or
replacement.  Signiﬁcant  TA  dilatation  is  deﬁned  by  a  dia-
stolic  diameter  ≥  40  mm  or  >  21  mm/m2 in  the  four-chamber
transthoracic  view,  and  is  considered  as  a  criterion  for
concomitant  tricuspid  procedure  in  case  of  left-sided  valve
surgery  [29].  Dreyfus  et  al.  classiﬁed  the  mode  of  leaﬂet
coaptation  as  body-to-body  in  case  of  normal  coaptation,
as  edge-to-edge  or  edge-to-body  in  case  of  symmetric  or
asymmetric  abnormal  coaptation,  and  as  lack  of  coaptation
in  case  of  gaping  valve  [80].  Quantiﬁcation  of  the  degree  of
leaﬂet  tethering  needs  measurement  of  the  coaptation  dis-
tance  and  the  tenting  area  [9].  Coaptation  distance  >  8  mm
and  tenting  area  >  1.6  cm2 characterize  signiﬁcant  tethering.
Measurements  of  tenting  volume  and  tenting  angles  from  3D
views  have  also  been  reported  to  independently  determine
residual  TR  after  tricuspid  annuloplasty  [24].
When  quantifying  TR,  echocardiographers  must  always
remember  the  marked  RV  plasticity  with  inspiratory  and
loading  changes,  and  bear  in  mind  the  resulting  poten-
tial  variations  of  TR  over  time,  on  a  short-time  scale  for
respiratory  variations  and  on  a  longer  time  scale  for  varia-
tions  caused  by  different  loading  conditions.  Topilsky  et  al.
nicely  showed  augmentation  of  TR  during  inspiration.  The
inspiratory  increase  in  regurgitant  oriﬁce  area  is  explained
by  inspiratory  annular  enlargement  and  RV  shape  widen-
ing,  resulting  in  decreased  valvular  coverage  and  increased
valvular  tenting  [81].  In  the  same  manner,  RV  morphological
t
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hanges  with  preload  and  afterload  variations  imply  poten-
ial  variability  of  TR  over  time.  So,  echocardiographic
nalysis  of  TR  should  always  take  place  after  medical  opti-
ization  of  loading  conditions,  and  rely  on  multiple  TR
easurements  averaged  over  the  respiratory  cycle.
Grading  the  severity  of  TR  is  not  an  easy  task.  There
s  general  agreement  about  trivial/mild  TR  seen  in  differ-
nt  views  by  colour  Doppler  as  a  small  central  regurgitant
lue  jet.  However,  the  sole  use  of  colour  ﬂow  imaging  to
uantify  higher  grades  of  TR  is  not  recommended,  as  it
s  limited  by  several  technical  and  haemodynamic  factors.
evertheless,  large  eccentric  jets,  swirling  and  reaching
he  posterior  wall  of  the  RA,  usually  indicate  signiﬁcant
R  [82].  Scientiﬁc  societies  in  Europe  and  the  USA  have
ublished  recommendations  for  the  quantiﬁcation  of  TR
29,30,82,83]. According  to  the  European  guidelines  and
any  experts  [47,80],  TR  should  be  quantiﬁed  in  three
rades  (mild,  moderate  and  severe)  using  the  classical  varia-
les  of  vena  contracta  width,  regurgitant  oriﬁce  area  and
egurgitant  volume  calculation  by  the  proximal  isovelocity
urface  area  (PISA)  method,  and  analysis  of  anterograde  and
egurgitant  ﬂow  proﬁles  and  hepatic  vein  ﬂow.  However,  all
hese  variables  are  less  robust  and  have  been  less  validated
or  TR  than  for  MR.  Furthermore,  the  shape  of  the  regur-
itant  oriﬁce  is  more  frequently  stellar  or  ellipsoid  than
ircular  in  TR,  and  multiple  jets  are  frequent,  disqualify-
ng  the  use  of  most  of  these  variables.  Nevertheless,  there
s  quite  a  consensus  for  the  deﬁnition  of  severe  TR  (triangu-
ar  ﬂow  with  early  peak,  E  tricuspid  velocity  >  1  m/s,  vena
ontracta  >  7  mm,  PISA  regurgitant  oriﬁce  area  >  40  mm2,
egurgitant  volume  >  45  mL  and  systolic  reversal  of  hepatic
ow),  but  the  boundaries  between  mild  and  moderate  TR
emain  poorly  deﬁned.
Finally,  echocardiography  also  evaluates  the
aemodynamic  consequences  of  TR,  with  the  analysis
f  the  inferior  vena  cava,  and  RA  and  RV  size  and  function.
owever,  right  heart  chamber  dilatation  and  RV  dysfunction
ay  not  only  be  the  consequence,  but  also  the  cause  of
R,  and  must  be  interpreted  with  special  attention  to
ulmonary  haemodynamics  and  clinical  context.
ardiac magnetic resonance analysis of
ricuspid regurgitation
n  in-plane  balanced  steady-state  free  precession  or  phase
ontrast  cine  imaging,  the  regurgitant  ﬂow  is  shown  on  CMR
s  a  triangular  jet  into  the  RA,  but  the  TR  jet  may  be  difﬁcult
o  evaluate  because  of  low  turbulence.  Obtaining  a  short-
xis  image  orthogonal  to  the  jet  ﬂow  is  the  ideal  means  of
cquiring  information  about  the  velocity  and  direction  of
ow.  Therefore,  the  jet  of  regurgitation,  especially  when  it
s  mild,  can  be  better  shown  by  gradient-recalled  echocar-
iography  imaging.  TR  is  best  imaged  in  the  four-chamber
iew  and  the  coronal  oblique  view  displaying  the  RA  and  the
V.  A  vena  contracta  >  7  mm  classiﬁes  TR  as  severe  [84—86].
TR  can  also  be  quantiﬁed  in  terms  of  regurgitant  vol-
me  and  fraction  in  similar  ways  to  mitral  regurgitation:
he  forward  stroke  volume,  as  measured  in  the  pulmonary
rtery  with  phase  contrast,  is  subtracted  from  the  total
V  stroke  volumes  from  the  steady-state  free  precession
mages  or  from  the  difference  in  right-left  ventricular  stroke
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olumes  [87].  However,  this  method  is  not  applicable  in  case
f  irregular  rhythms  or  signiﬁcant  other  valve  regurgitation.
atural history and prognostic implications
any  studies  have  underlined  the  poor  prognosis  associ-
ted  with  severe  TR.  In  a  recent  study  of  350  patients
ith  isolated  TR,  the  10-year  survival  rate  was  lower  with
n  regurgitant  oriﬁce  area  >  40  mm2 vs.  <  40  mm2 (39%  vs.
1%),  independent  of  all  characteristics,  RV  size  or  function,
o-morbidity  or  pulmonary  pressure,  and  was  lower  than
xpected  in  the  general  population  [88].  In  the  follow-up
f  200  patients  with  mild  TR,  all-cause  mortality  at  3  years
as  20%  for  patients  without  TR  progression,  42%  for  mod-
rate  TR  and  63%  for  severe  TR,  and  progression  to  severe
R  independently  predicted  subsequent  mortality  [55]. Sim-
lar  results  have  been  found  in  the  follow-up  of  left-sided
eart  valve  surgery,  with  a  better  prognosis  and  improved
ong-term  right-sided  remodelling  in  patients  who  undergo
oncomitant  tricuspid  annuloplasty  [89],  and  a  poorer  prog-
osis  in  patients  with  residual  and/or  late  progression  of  TR
57,90].  Furthermore,  in  those  patients,  there  is  high  mor-
idity  and  mortality  associated  with  reoperative  open-heart
urgery,  partly  as  a  result  of  the  unpredictable  evolution  of
he  RV  [91].  So,  a  combined  procedure  on  TR  at  the  time
f  surgery  is  increasingly  supported  by  published  guidelines,
espite  the  lack  of  randomized  data  proving  its  beneﬁt  [92].
onclusion
ncreased  mortality  among  patients  with  TR,  regardless  of
ulmonary  pressure,  RV  function  or  left  heart  valve  disease
as  revived  interest  in  the  TV.  The  optimal  analysis  of  the
V  should  be  achieved  through  a  perfect  knowledge  of  its
natomy,  function  and  pathophysiology,  and  through  a  thor-
ugh  evaluation  with  multimodality  imaging.  2D,  3D  TTE
nd  TOE,  together  with  CT  scans  and  CMR,  allow  the  accu-
ate  morphological  description  of  the  TV  complex,  including
eaﬂets,  subvalvular  apparatus  and  the  TA,  and  quantitative
valuation  of  TR  and  RV  function.  However,  the  selection  of
atients  who  will  beneﬁt  from  surgical  repair  or  replacement
f  the  TV,  either  in  isolation  or  combined  with  another  surgi-
al  procedure  on  the  left  heart,  is  a  subject  of  hot  debate  in
he  ﬁeld  of  heart  valve  disease,  and  the  development  of  new
ercutaneous  procedures  further  adds  to  the  complexity  of
his  issue.
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